Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
Noise can play an important role in the initiation and progression of ischemic heart disease. Researchers from the Department of Cardiology at the University Medical Center Mainz have found that noise exposure...
Read Full NewsFrontlines with Frontera, a podcast hosted by neurointensivist Jennifer Frontera, MD, brings you an exclusive interview with Sahar Zafar, MD, MBBS. [LISTEN TIME: 30 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 19, 2025.
GLP-1 research in neurology is on the rise, with several pivotal studies lending insights into their role.
Fear of Movement, Central Sensitization May Worsen Outcomes in Gout
FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026
FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease
Weight-Loss Interventions Improve Psoriasis Severity, Quality of Life
1.
Chemo causes lasting physical decline in breast cancer survivors
2.
Virtual Reality Travel Reduces Cancer Pain.
3.
High weight and obesity are associated with poor outcomes in leukemia treatment.
4.
Transplantation Fails to Improve Survival in Mantle Cell Lymphoma
5.
Second opinions don't significantly delay breast cancer treatment
1.
Improving TIVAP Use: Review of Standardization and Optimization Practices
2.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
3.
Understanding Axitinib: What You Need To Know For Your Treatment Plan
4.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
5.
Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge